NasdaqGS:SANABiotechs
Will Sana’s New Veteran Biopharma CFO Appointment Change Sana Biotechnology's (SANA) Investment Narrative
On February 17, 2026, Sana Biotechnology appointed Brian Piper, M.B.A., as Chief Financial Officer, Executive Vice President, Treasurer, and Principal Financial Officer, ending CEO Steven Harr’s tenure as acting Principal Financial Officer.
The move brings a veteran finance leader with extensive public biopharma and IPO experience into Sana’s top ranks, potentially reshaping how the company approaches capital allocation and investor engagement.
We’ll explore how bringing in an experienced...